MedEquity distinguishes itself from many private equity firms with our “top-down” investment process. This involves exploring and evaluating sectors within the healthcare industry in order to develop an investment thesis around specific areas of interest, opportunity, and growth. Because our team brings together a diverse set of healthcare backgrounds and an extensive experience base, we are better able to navigate the investment risks and returns across the healthcare spectrum. Before targeting a sector for potential investment, we engage in a thorough and thoughtful review of critical considerations such as: changes in payor and reimbursement dynamics, the impact of new technologies, shifts in consumer demographics and preferences, and the cost drivers that may affect the setting in which care is delivered. Historically, this refined investment approach has allowed us to develop long-term relationships with senior industry executives who either run or are involved with growing healthcare companies that are, in turn, attractive investment opportunities. As such, many of our prospects are privately-owned businesses seeking capital on a direct basis or outside of a formal process.